Axios @axios
The FDA approved Zynteglo, a gene therapy that treats patients with the blood disorder beta-thalassemia. The one-time treatment comes at a record price of $2.8 million. https://t.co/BpEjdu49tJ — PolitiTweet.org
Created
Sun Aug 21 06:57:30 +0000 2022
Likes
23
Retweets
16
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
The FDA approved Zynteglo, a gene therapy that treats patients with the blood disorder beta-thalassemia. The one-time treatment comes at a record price of $2.8 million. https://t.co/BpEjdu49tJ — PolitiTweet.org